Drug intelligence / Profile preview

ergotamine + caffeine + acetylsalicylic acid + homatropine

Development stage
Unknown
Lead developer
EMS
Modality
Small Molecules
Administration
Oral, Rectal
01

Overview

A combination medication containing **ergotamine, caffeine, acetylsalicylic acid (aspirin), and homatropine**. This oral formulation is indicated for the **acute treatment of migraine and cluster headaches**. - **Ergotamine** is an ergot alkaloid that acts as a vasoconstrictor, reducing dilation in cranial blood vessels. - **Caffeine** enhances the absorption and vasoconstrictive effect of ergotamine. - **Acetylsalicylic acid (aspirin)** is a nonsteroidal anti-inflammatory drug (NSAID) that provides analgesic and anti-inflammatory effects. - **Homatropine** is an anticholinergic agent typically added at very low doses to reduce excessive cholinergic (gastrointestinal and central nervous system) side effects. The combination aims to relieve headache pain through multiple mechanisms: vascular constriction, reduction in neurogenic inflammation, central analgesia, and mitigation of certain side effects.

02

Targets

ADORA2A (Adenosine A₂A Receptor)mAChR (Muscarinic acetylcholine receptors)HTR1B (5-Hydroxytryptamine Receptor 1B)HTR1D (5-hydroxytryptamine receptor 1D)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)ADORA1 (Adenosine receptor A1 subtype)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on ergotamine + caffeine + acetylsalicylic acid + homatropine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ergotamine + caffeine + acetylsalicylic acid + homatropine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call